Journey Medical Corp (DERM) Institutional Ownership

Ownership Summary

Journey Medical Corp (NASDAQ:DERM) has 1 institutional investors with active 13F positions as of March 2020.

• Their combined ownership stood at 0.0% of outstanding shares in March 2020, down from 537.0% in December 2019.
• Their total shares held in DERM decreased -100.0% from the prior quarter, while the number of investors in Journey Medical stayed flat year over year.
• During the quarter, 0 of these 1 funds increased positions in DERM, 1 reduced exposure, and 0 held steady.
• In total, institutional investors held 0 shares in Journey Medical as of March 2020, down by 4.19K shares quarter on quarter, and with no net change year over year.
• WASATCH ADVISORS LP leads ownership in DERM with 2.13Mn shares as of March 31, 2020, equal to 21.17% of outstanding shares.
• The most significant purchases of DERM for the quarter ending March 2020 came from VANGUARD CAPITAL MANAGEMENT LLC (1.08Mn), WASATCH ADVISORS LP (817.1K), BlackRock, Inc. (253.08K), GEODE CAPITAL MANAGEMENT, LLC (149.23K), Diametric Capital, LP (144.73K).
• Leading sellers of Journey Medical shares for the quarter ending March 2020 were Opaleye Management Inc. (990.0K), J. Goldman & Co LP (298.18K), TANG CAPITAL MANAGEMENT LLC (244.6K), MILLENNIUM MANAGEMENT LLC (74.74K), BNP PARIBAS FINANCIAL MARKETS (23.17K).
• According to Business Quant data, leading holders of DERM for March 2020 are WASATCH ADVISORS LP (2.13Mn), TANG CAPITAL MANAGEMENT LLC (1.61Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.08Mn), BlackRock, Inc. (972.86K), Opaleye Management Inc. (960.0K), J. Goldman & Co LP (500.19K), Pale Fire Capital SE (481.99K), GEODE CAPITAL MANAGEMENT, LLC (463.2K), UBS Group AG (390.14K), MILLENNIUM MANAGEMENT LLC (383.07K).